1. Home
  2. COHU vs MESO Comparison

COHU vs MESO Comparison

Compare COHU & MESO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cohu Inc.

COHU

Cohu Inc.

N/A

Current Price

$49.86

Market Cap

1.9B

Sector

Industrials

ML Signal

N/A

Logo Mesoblast Limited

MESO

Mesoblast Limited

N/A

Current Price

$15.04

Market Cap

1.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
COHU
MESO
Founded
1947
2004
Country
United States
Australia
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
1.8B
IPO Year
1994
2005

Fundamental Metrics

Financial Performance
Metric
COHU
MESO
Price
$49.86
$15.04
Analyst Decision
Strong Buy
Buy
Analyst Count
8
3
Target Price
★ $74.63
$37.00
AVG Volume (30 Days)
★ 1.1M
260.7K
Earning Date
10-28-2026
08-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
N/A
Revenue
★ $452,956,000.00
N/A
Revenue This Year
$37.74
$51.86
Revenue Next Year
$33.35
$63.33
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 12.74
N/A
52 Week Low
$21.10
$11.89
52 Week High
$75.72
$21.50

Technical Indicators

Market Signals
Indicator
COHU
MESO
Relative Strength Index (RSI) 39.87 57.26
Support Level $49.06 $13.77
Resistance Level $52.43 $16.06
Average True Range (ATR) 3.78 0.45
MACD -0.80 0.31
Stochastic Oscillator 22.47 78.63

Price Performance

Historical Comparison
COHU
MESO

About COHU Cohu Inc.

Cohu Inc is a supplier of semiconductor test and inspection handlers, micro-electro-mechanical system (MEMS) test modules, test contactors, and thermal sub-systems used by semiconductor manufacturers and test subcontractors. The company's products include Semiconductor ATE (Automated Test Equipment), Semiconductor Handlers, Interface Products such as test contactors, probe heads, and probe pins, Spares and Kits, Bare Board PCB Test Systems, and services. It has one reportable segment, Semiconductor Test and Inspection Equipment (Semiconductor Test & Inspection). Geographically, the company generates maximum revenue from the Philippines, followed by Taiwan, China, Malaysia, the United States, Singapore, and the Rest of the world.

About MESO Mesoblast Limited

Mesoblast Ltd is a commercial-stage biotechnology company engaged in developing and commercializing allogeneic (off-the-shelf) cellular medicines for severe inflammatory conditions. Its commercial product, Ryoncil (remestemcel-L-rknd), is FDA-approved for steroid-refractory acute graft-versus-host disease in pediatric patients. The company is also developing Ryoncil for additional inflammatory indications. Its rexlemestrocel-L platform is being developed for chronic low back pain associated with degenerative disc disease and chronic heart failure. The company operates as a single segment focused on its allogeneic cellular medicines platform.

Share on Social Networks: